165 related articles for article (PubMed ID: 38077440)
1. Inhibition of non-small cell lung cancer (NSCLC) proliferation through targeting G6PD.
Chanda M; Anuntasomboon P; Ruangritchankul K; Cheepsunthorn P; Cheepsunthorn CL
PeerJ; 2023; 11():e16503. PubMed ID: 38077440
[TBL] [Abstract][Full Text] [Related]
2. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression.
Wu Q; Ge XL; Geng ZK; Wu H; Yang JY; Cao SR; Yang AL
Heliyon; 2024 Feb; 10(3):e25144. PubMed ID: 38322888
[TBL] [Abstract][Full Text] [Related]
3. G6PD Maintains Redox Homeostasis and Biosynthesis in LKB1-Deficient KRAS-Driven Lung Cancer.
Lan T; Arastu S; Wang S; Lam J; Wang W; Bhatt V; Lopes EC; Hu Z; Sun M; Luo X; Ghergurovich JM; Li C; Su X; Rabinowitz JD; White E; Guo JY
bioRxiv; 2023 Oct; ():. PubMed ID: 37873106
[TBL] [Abstract][Full Text] [Related]
4. [A Novel Chinese Medicine Formula Inhibits Non-small Cell Lung Cancer by Triggering Oxidative Stress Dependent on Pentose Phosphate Pathway].
Cheng C; Wu W; Yu J; Yuan D; Wang Y; Li L
Zhongguo Fei Ai Za Zhi; 2023 Sep; 26(9):639-649. PubMed ID: 37985150
[TBL] [Abstract][Full Text] [Related]
5. The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers.
Ahamed A; Hosea R; Wu S; Kasim V
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139067
[TBL] [Abstract][Full Text] [Related]
6. KLF8 Promotes the Survival of Lung Adenocarcinoma During Nutrient Deprivation by Regulating the Pentose Phosphate Pathway through SIRT2.
Bai Q; Jin W; Chen F; Zhu J; Cao L; Yang Y; Zhong F; Li L
Front Biosci (Landmark Ed); 2024 Jan; 29(1):27. PubMed ID: 38287804
[TBL] [Abstract][Full Text] [Related]
7. Tin Mesoporphyrin Selectively Reduces Non-Small-Cell Lung Cancer Cell Line A549 Proliferation by Interfering with Heme Oxygenase and Glutathione Systems.
Sorrenti V; D'Amico AG; Barbagallo I; Consoli V; Grosso S; Vanella L
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34205698
[TBL] [Abstract][Full Text] [Related]
8. TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo.
Dong LH; Li L; Song Y; Duan ZL; Sun SG; Lin YL; Miao SB; Yin YJ; Shu YN; Li H; Chen P; Zhao LL; Han M
Circ Res; 2015 Sep; 117(8):684-94. PubMed ID: 26291555
[TBL] [Abstract][Full Text] [Related]
9. Targeting epidermal growth factor receptor in paclitaxel-resistant human breast and lung cancer cells with upregulated glucose-6-phosphate dehydrogenase.
Min HY; Lee HJ; Suh YA; Pei H; Kwon H; Jang HJ; Yun HJ; Moon HG; Lee HY
Br J Cancer; 2022 Sep; 127(4):661-674. PubMed ID: 35597872
[TBL] [Abstract][Full Text] [Related]
10. Cytosolic malic enzyme and glucose-6-phosphate dehydrogenase modulate redox balance in NSCLC with acquired drug resistance.
Ran M; Zhou Y; Guo Y; Huang D; Zhang SL; Tam KY
FEBS J; 2023 Oct; 290(19):4792-4809. PubMed ID: 37410361
[TBL] [Abstract][Full Text] [Related]
11. A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC.
Yang H; Chen D; Wu Y; Zhou H; Diao W; Liu G; Li Q
Cancer Metab; 2023 Dec; 11(1):27. PubMed ID: 38111012
[TBL] [Abstract][Full Text] [Related]
12. G6PD promotes cell proliferation and dexamethasone resistance in multiple myeloma via increasing anti-oxidant production and activating Wnt/β-catenin pathway.
Li R; Ke M; Qi M; Han Z; Cao Y; Deng Z; Qian J; Yang Y; Gu C
Exp Hematol Oncol; 2022 Oct; 11(1):77. PubMed ID: 36271440
[TBL] [Abstract][Full Text] [Related]
13. PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis.
Hong X; Song R; Song H; Zheng T; Wang J; Liang Y; Qi S; Lu Z; Song X; Jiang H; Liu L; Zhang Z
Gut; 2014 Oct; 63(10):1635-47. PubMed ID: 24352616
[TBL] [Abstract][Full Text] [Related]
14. The Transcription Coregulator RIP140 Inhibits Cancer Cell Proliferation by Targeting the Pentose Phosphate Pathway.
Jacquier V; Gitenay D; Cavaillès V; Teyssier C
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806424
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System.
Hong W; Cai P; Xu C; Cao D; Yu W; Zhao Z; Huang M; Jin J
Front Pharmacol; 2018; 9():43. PubMed ID: 29445340
[TBL] [Abstract][Full Text] [Related]
16. Targeting glucose-6-phosphate dehydrogenase by 6-AN induces ROS-mediated autophagic cell death in breast cancer.
Li Y; Zheng F; Zhang Y; Lin Z; Yang J; Han X; Feng Y; Pei X; Li F; Liu Q; Yan L; Li T; Zhang Y; Li D; Fu Z; Wang C; Sun Q; Li C
FEBS J; 2023 Feb; 290(3):763-779. PubMed ID: 36048131
[TBL] [Abstract][Full Text] [Related]
17. The TGFβ1-FOXM1-HMGA1-TGFβ1 positive feedback loop increases the cisplatin resistance of non-small cell lung cancer by inducing G6PD expression.
Zhang R; Tao F; Ruan S; Hu M; Hu Y; Fang Z; Mei L; Gong C
Am J Transl Res; 2019; 11(11):6860-6876. PubMed ID: 31814893
[TBL] [Abstract][Full Text] [Related]
18. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
19. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
20. PBX3 promotes pentose phosphate pathway and colorectal cancer progression by enhancing G6PD expression.
Luo X; Wei M; Li W; Zhao H; Kasim V; Wu S
Int J Biol Sci; 2023; 19(14):4525-4538. PubMed ID: 37781025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
